The angiotensin-converting enzyme (ACE) inhibitors available today include Captopril (Capoten), enalapril (Vasotec), enaloprilat (Vasotec IV), lisinopril (Prinivil, Zestril), benazepril (Lotensin), fosinopril (Monopril), and ramipril (Atace). These drugs are used in the treatment of hypertension and congestive heart failure. They also are used in treating renovascular hypertension not amenable to surgery and are being studied to decrease left ventricular size after infarction and to determine whether they slow the rate of internal hyperplasia. Angiotensin-converting enzyme inhibitors have negative inotropic and chronotropic effects. This chapter discusses the ACE inhibitors and their actions, uses, adverse effects, contraindications, and nursing implications
Skip Nav Destination
Cardiovascular Pharmacology| May 01 1992
Angiotensin-Converting Enzyme Inhibitors
Merrily Kuhn, RNC, PhD, CCRN
From Educational Services, Hamburg, New York, and Daemen College, Buffalo, New York.
Reprint requests to Merrily Kuhn, RNC, PhD, CCRN, Educational Services, 6748 Boston State Rd., Hamburg, NY 14075.
Search for other works by this author on:
AACN Adv Crit Care (1992) 3 (2): 461–471.
Merrily Kuhn; Angiotensin-Converting Enzyme Inhibitors. AACN Adv Crit Care 1 May 1992; 3 (2): 461–471. doi: https://doi.org/10.4037/15597768-1992-2017
Download citation file:
Don't already have an account? Register
AACN AccountSign In
Sign in via your InstitutionSign in via your Institution
Subscribe online and gain access to the entire archive.
Purchase short-term access on a pay-per-article or pay-per-issue basis.
$15 72 - hour single article access $30 7 - day full issue access